This Week in Pediatric Oncology
Science
TWiPO #96: GPC2 Directed Immunotherapy for GPC2 Expressing Solid Tumors with Dr. Kristopher Bosse
TWiPO #95: Patient Advocates’ Views in Neuroblastoma with Nick Bird & Donna Ludwinski
TWiPO #94: Improved Outcome in Pediatric High-Risk Neuroblastoma with Dr. Wayne Furman
TWiPO #93: CureWorks & Caring Cross: Pathways to Advance Cell & Gene Therapy with Dr. Rimas Orentas
TWiPO #92: mRNA - Not just for COVID - What is its Application in Pediatric Cancer? with Dr. Elias Sayour
TWiPO #91: What Breakthroughs are on the Horizon for DIPG? with Dr. Mariella Filbin
TWiPO #90: Newborn Screening For Predisposition to Pediatric Cancers with Dr. Lisa Diller
TWiPO #89: Spotlight on Immunotherapy for Pediatrics - Natural Killer T-Cells with Dr. Andras Heczey
TWiPO #88: The ACCELERATE ALKi Pediatric Strategy Forum with Prof. Andy Pearson & Prof. Lou Chesler
TWiPO #87: Biotech Solutions for Pediatric Cancer Drug Development with Dr. Samuel Blackman
TWiPO #86: Oncolytic Virotherapy in Pediatric Brain Tumors with Dr. Gregory Friedman
TWiPO #85: Brain Tumors & The Blood-Brain Barrier with Dr. Stergios Zacharoulis
TWiPO #84: An Introduction to the ACCELERATE Platform with Dr. Gilles Vassal & Patricia Blanc
TWiPO #83 - Dr. Christopher Dandoy on transplant-associated thrombotic microangiopathy (TA-TMA)
TWiPO #82: Dr. Brenda Weigel on The RACE Act & Early Phase Clinical Trials
Discussing Brain Tumor Research with Dr. Michael Taylor & Dr. Nabil Ahmed
TWIPO: Interview with Douglas Hawkins, MD - Chair of Children's Oncology Group (COG)
The Pandemic's Impact on the Pediatric Cancer Research Landscape
Latest COVID-19 Insights from Doctors + Stories from the Frontline to inform Childhood Cancer Families & the General Community
Discussion on Impact of COVID-19 in the Pediatric Cancer Community
Copyright © 2006-2022 Podbean.com